{"favorite_id": 2154, "calc_type": "calculator", "dosing": false, "full_title_en": "SSIGN Score for Renal Cell Carcinoma (RCC)", "short_title_en": "SSIGN Score", "medium_description_en": "Predicts progression of clear cell renal cell carcinoma after radical nephrectomy.", "short_description_en": "Prognosis of clear cell RCC.", "before_use": "", "instructions_en": "", "purpose_en": ["Prognosis"], "disease_en": ["Cancer", "Renal Cell Carcinoma", "Chemotherapy"], "specialty_en": ["Hematology and Oncology", "Nephrology", "Palliative Care/Hospice", "Urology"], "chief_complaint_en": ["Hematuria"], "system_en": ["Oncologic", "Renal", "Urinary"], "search_abbreviation_en": ["nephrectomy", "RCC", "prognosis", "renal", "clear cell"], "slug": "ssign-score-renal-cell-carcinoma-rcc", "seo": {"meta_description_en": "SSIGN Score for Renal Cell Carcinoma (RCC) predicts progression of clear cell renal cell carcinoma after radical nephrectomy.", "keywords_en": "ssign score, ssign rcc, stage rcc score, size rcc score, grade rcc score, necrosis rcc score, renal cell carcinoma score, rcc score, stage size grade necrosis, radical nephrectomy, clear cell rcc nephrectomy"}, "content": {"how_to_use": {"use_case_en": "", "pearls_pitfalls_en": "<ul> <li>The SSIGN (Stage, Size, Grade and Necrosis) score applies to clear cell renal cell carcinoma (RCC) at all stages, but not to other types of RCC.</li> <li>Validated in multiple patient cohorts.</li> </ul>", "why_use_en": ""}, "next_steps": {"advice_en": "<p>Some experts believe this score should <b>not</b> be used as a single prognostic system in all histologic subgroups. Consider other prognostic systems.</p>", "management_en": "<p>Refer to&nbsp;<guideline id=\"10121\">AUA guidelines</guideline>&nbsp;for management of renal cancer.</p>", "critical_actions_en": ""}, "about": {"formula_en": "<p>Addition of selected points.</p>", "more_info_en": "<p><strong>Predicted Outcomes</strong></p> <div class='table-responsive'> <table class='table table-bordered table-hover'> <tbody> <tr> <th></th> <th colspan='5'>% estimated cancer-specific survival rates</th> </tr> <tr> <td><strong>SSIGN Score</strong></td> <td><strong>Year 1</strong></td> <td><strong>Year 3</strong></td> <td><strong>Year 5</strong></td> <td><strong>Year 7</strong></td> <td><strong>Year 10</strong></td> </tr> <tr> <td>0 - 2</td> <td>99.7</td> <td>98.7</td> <td>97.3</td> <td>96</td> <td>93.6</td> </tr> <tr> <td>3 - 4</td> <td>98.1</td> <td>93.4</td> <td>89.8</td> <td>84</td> <td>77.9</td> </tr> <tr> <td>5 - 6</td> <td>92.9</td> <td>83.8</td> <td>74.1</td> <td>65</td> <td>57.3</td> </tr> <tr> <td>7 - 9</td> <td>76.5</td> <td>46.9</td> <td>38.6</td> <td>29</td> <td>25.9</td> </tr> <tr> <td>\u2265 10</td> <td>43.3</td> <td>21.9</td> <td>19.2</td> <td>19.2</td> <td>19.2</td> </tr> </tbody> </table> </div>", "evidence_based_medicine_en": "", "references_list": {"Original/Primary Reference": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/12441925", "text": "Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumour stage, size, grade and necrosis: the SSIGN score. J Urol 2002; 168:2395\u2013400."}], "Other References": [{"href": "http://onlinelibrary.wiley.com/doi/10.1002/cncr.11234/full", "text": "Leibovich BC, Blute M, Cheville JC, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003;97:1663-1671"}, {"href": "http://annonc.oxfordjournals.org/content/23/suppl_7/vii65.full", "text": "Escudier B, Eisen T, Porta C, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2012; 23(suppl 7):vii65\u2013vii71."}], "Validation": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/19062157", "text": "Zigeuner R, Hutterer G, Chromecki T, Imamovic A, Kampel-Kettner K, Rehak P, Langner C, Pummer K. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. Eur Urol. 2010 Jan;57(1):102-9."}], "Clinical Practice Guidelines": [{"href": "", "text": ""}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": []}, "reviewer": {"expert_name": []}, "creator": [{"name": "Dr. Igor Frank", "creator_info": {"deceased": null, "about_en": "<p>Igor Frank, MD, is a professor of urology at the Mayo Clinic in Rochester, MN. Currently, he is the head of the Mayo Clinic bladder removal (cystectomy) registry. His research focuses mainly on treatment and prognosis of survival in bladder and prostate cancer, though he also researches continuity and quality of care for cancer patients.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-igor-frank.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Frank+I%5BAuthor%5D"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [{"society": "American Urological Association", "link": "https://www.mdcalc.com/guidelines/other/renal-mass-localized-renal-cancer", "text": "Renal Mass and Localized Renal Cancer", "description": "Guideline from AUA"}], "teaching": [], "videos": [], "interests": [{"link": "https://www.mdcalc.com/rcc-renal-cell-carcinoma-practice-pearls", "text": "Practice Pearls: Renal Cell Carcinoma"}], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "radio", "label_en": "Pathological T category", "name": "t", "options": [{"label": "pT1", "value": 0}, {"label": "pT2", "value": 1}, {"label": "pT3a-c", "value": 2}, {"label": "pT4", "value": 4}], "conditionality": "", "show_points": true, "default": 0, "tips_en": "As per 2002 TNM staging guidelines", "optional": false}, {"type": "radio", "label_en": "Regional lymph node status", "name": "n", "options": [{"label": "pNx or pN0", "value": 0}, {"label": "pN1 or pN2", "value": 2}], "conditionality": "", "show_points": true, "default": 0, "tips_en": "As per 2002 TNM staging guidelines", "optional": false}, {"type": "radio", "label_en": "Metastasis category", "name": "m", "options": [{"label": "M0", "value": 0}, {"label": "M1", "value": 4}], "conditionality": "", "show_points": true, "default": 0, "tips_en": "As per 2002 TNM staging guidelines", "optional": false}, {"type": "radio", "label_en": "Tumor size", "name": "tumor", "options": [{"label": "<5 cm", "value": 0}, {"label": "\u22655 cm", "value": 2}], "conditionality": "", "show_points": true, "default": 0, "optional": false}, {"type": "radio", "label_en": "<calculator id='3012'>Tumor (nuclear) grade</calculator>", "name": "nuc", "options": [{"label": "1 or 2", "value": 0}, {"label": "3", "value": 1}, {"label": "4", "value": 3}], "conditionality": "", "show_points": true, "default": 0, "optional": false}, {"type": "radio", "label_en": "Tumor necrosis present", "name": "nec", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 2}], "conditionality": "", "show_points": true, "default": 0, "optional": false}], "md5": "8937087b3a21d8d563d43dbb5f025fbe", "related_calcs": [{"calcId": 3012, "short_title_en": "Fuhrman Nuclear Grade", "slug": "fuhrman-nuclear-grade-clear-cell-renal-carcinoma"}, {"calcId": 2153, "short_title_en": "MSKCC/Motzer Criteria for RCC", "slug": "memorial-sloan-kettering-cancer-center-mskcc-motzer-score-metastatic-renal-cell-carcinoma-rcc"}, {"calcId": 3908, "short_title_en": "RENAL Nephrometry Score", "slug": "renal-nephrometry-score"}]}